PureTech Health PLC (GB:PRTC)
LSE:PRTC
Want to see GB:PRTC full AI Analyst Report?
Total Valuation
PureTech Health has a market cap or net worth of £312.55M. The enterprise value is 179.63M .
Market Cap£312.55M
Enterprise Value179.63M
Share Statistics
PureTech Health has 243,418,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding243,418,180
Owned by Insiders3.60%
Owned by Institutions0.11%
Financial Efficiency
PureTech Health’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -20.08%.
Return on Equity (ROE)-0.36
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-20.08%
Return on Capital Employed (ROCE)-0.21
Revenue Per Employee59.46K
Profits Per Employee-1.40M
Employee Count80
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PureTech Health is ―. PureTech Health’s PEG ratio is 0.01.
PE Ratio―
PS Ratio85.14
PB Ratio1.30
Price to Fair Value1.30
Price to FCF-4.66
Price to Operating Cash Flow-0.48
PEG Ratio0.01
Income Statement
In the last 12 months, PureTech Health had revenue of 4.76M and earned -112.04M in profits. Earnings per share was -0.47.
Revenue4.76M
Gross Profit1.34M
Operating Income-100.59M
Pretax Income-113.25M
Net Income-112.04M
EBITDA-97.17M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was -83.81M and capital expenditures -6.03K, giving a free cash flow of -83.82M billion.
Operating Cash Flow-83.81M
Free Cash Flow-83.82M
Free Cash Flow per Share-0.34
Dividends & Yields
PureTech Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.47
52-Week Price Change3.72%
50-Day Moving Average122.35
200-Day Moving Average127.41
Relative Strength Index (RSI)68.57
Average Volume (3m)444.90K
Important Dates
PureTech Health upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateApr 29, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
PureTech Health as a current ratio of 6.59, with Debt / Equity ratio of 6.33%
Current Ratio6.59
Quick Ratio6.59
Debt to Market Cap0.02
Net Debt to EBITDA2.41
Interest Coverage Ratio-2.15
Taxes
In the past 12 months, PureTech Health has paid -859.66K in taxes.
Income Tax-859.66K
Effective Tax Rate<0.01
Enterprise Valuation
PureTech Health EV to EBITDA ratio is -1.76, with an EV/FCF ratio of -1.96.
EV to Sales35.86
EV to EBITDA-1.76
EV to Free Cash Flow-1.96
EV to Operating Cash Flow-1.96
Balance Sheet
PureTech Health has £279.00M in cash and marketable securities with £19.76M in debt, giving a net cash position of £259.23M billion.
Cash & Marketable Securities£279.00M
Total Debt£19.76M
Net Cash£259.23M
Net Cash Per Share£1.06
Tangible Book Value Per Share£1.27
Margins
Gross margin is -471.15%, with operating margin of -2114.72%, and net profit margin of -2355.42%.
Gross Margin-471.15%
Operating Margin-2114.72%
Pretax Margin-2380.90%
Net Profit Margin-2355.42%
EBITDA Margin-2042.86%
EBIT Margin-2114.72%
Analyst Forecast
The average price target for PureTech Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.89%
EPS Growth Forecast-310.69%